@prefix ns1: <http://linked.opendata.cz/ontology/drug-encyclopedia/> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix xml: <http://www.w3.org/XML/1998/namespace> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<http://linked.opendata.cz/resource/ATC/J05AB04> a ns1:ATCConcept ;
    skos:notation "J05AB04" ;
    skos:prefLabel "Ribavirin"@cs,
        "Ribavirin"@en .

<http://linked.opendata.cz/resource/drug-encyclopedia/ingredient/M0019062> a ns1:Ingredient ;
    ns1:contraindicatedWith <http://linked.opendata.cz/resource/ndfrt/disease/N0000000384>,
        <http://linked.opendata.cz/resource/ndfrt/disease/N0000000999>,
        <http://linked.opendata.cz/resource/ndfrt/disease/N0000001432>,
        <http://linked.opendata.cz/resource/ndfrt/disease/N0000001472>,
        <http://linked.opendata.cz/resource/ndfrt/disease/N0000003529>,
        <http://linked.opendata.cz/resource/ndfrt/disease/N0000003952>,
        <http://linked.opendata.cz/resource/ndfrt/disease/N0000010195> ;
    ns1:description "A nucleoside antimetabolite antiviral agent that blocks nucleic acid synthesis and is used against both RNA and DNA viruses.     "@en ;
    ns1:hasMechanismOfAction <http://linked.opendata.cz/resource/ndfrt/mechanism-of-action/N0000000133> ;
    ns1:hasMedicinalProduct <http://linked.opendata.cz/resource/sukl/medicinal-product/COPEGUS-200-MG>,
        <http://linked.opendata.cz/resource/sukl/medicinal-product/REBETOL-200-MG>,
        <http://linked.opendata.cz/resource/sukl/medicinal-product/REBETOL-40-MG-ML>,
        <http://linked.opendata.cz/resource/sukl/medicinal-product/RIBAVIRIN-BIOPARTNERS-200-MG>,
        <http://linked.opendata.cz/resource/sukl/medicinal-product/RIBAVIRIN-MYLAN-200-MG>,
        <http://linked.opendata.cz/resource/sukl/medicinal-product/RIBAVIRIN-MYLAN-200-MG-POTAHOVANE-TABLETY>,
        <http://linked.opendata.cz/resource/sukl/medicinal-product/RIBAVIRIN-TEVA-200-MG>,
        <http://linked.opendata.cz/resource/sukl/medicinal-product/RIBAVIRIN-TEVA-PHARMA-BV-200-MG>,
        <http://linked.opendata.cz/resource/sukl/medicinal-product/RIBAVIRIN-TEVA-PHARMA-BV-400-MG>,
        <http://linked.opendata.cz/resource/sukl/medicinal-product/VILARIB-200-MG-POTAHOVANE-TABLETY>,
        <http://linked.opendata.cz/resource/sukl/medicinal-product/VILARIB-200-MG-TVRDE-TOBOLKY>,
        <http://linked.opendata.cz/resource/sukl/medicinal-product/VILARIB-400-MG-POTAHOVANE-TABLETY>,
        <http://linked.opendata.cz/resource/sukl/medicinal-product/VILARIB-600-MG-POTAHOVANE-TABLETY> ;
    ns1:hasPharmacologicalAction <http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0001470>,
        <http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0001518> ;
    ns1:hasPhysiologicEffect <http://linked.opendata.cz/resource/ndfrt/physiologic-effect/N0000008577>,
        <http://linked.opendata.cz/resource/ndfrt/physiologic-effect/N0000008853> ;
    ns1:hasPregnancyCategory <http://linked.opendata.cz/resource/fda-spl/pregnancy-category/X> ;
    ns1:mayTreat <http://linked.opendata.cz/resource/ndfrt/disease/N0000000315>,
        <http://linked.opendata.cz/resource/ndfrt/disease/N0000001509>,
        <http://linked.opendata.cz/resource/ndfrt/disease/N0000001681>,
        <http://linked.opendata.cz/resource/ndfrt/disease/N0000003161>,
        <http://linked.opendata.cz/resource/ndfrt/disease/N0000003803>,
        <http://linked.opendata.cz/resource/ndfrt/disease/N0000003954> ;
    ns1:title "Ribavirin"@cs,
        "Ribavirin"@en .

<http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0001470> a ns1:PharmacologicalAction ;
    ns1:description "Drugs that are chemically similar to naturally occurring metabolites, but differ enough to interfere with normal metabolic pathways. (From AMA Drug Evaluations Annual, 1994, p2033)     "@en ;
    ns1:title "Antimetabolity"@cs,
        "Antimetabolites"@en .

<http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0001518> a ns1:PharmacologicalAction ;
    ns1:description "Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly.     "@en ;
    ns1:title "Antivirové látky"@cs,
        "Antiviral agents"@en .

<http://linked.opendata.cz/resource/ndfrt/disease/N0000000315> a ns1:DiseaseOrFinding ;
    ns1:description "Respiratory and conjunctival infections caused by 33 identified serotypes of human adenoviruses.     "@en ;
    ns1:title "Adenovirové infekce lidí"@cs,
        "Adenovirus infections, human"@en .

<http://linked.opendata.cz/resource/ndfrt/disease/N0000000384> a ns1:DiseaseOrFinding ;
    ns1:description "A reduction in the number of circulating erythrocytes or in the quantity of hemoglobin.     "@en ;
    ns1:title "Anemie"@cs,
        "Anemia"@en .

<http://linked.opendata.cz/resource/ndfrt/disease/N0000000999> a ns1:DiseaseOrFinding ;
    ns1:description "Immunologically mediated adverse reactions to medicinal substances used legally or illegally.     "@en ;
    ns1:title "Léková alergie"@cs,
        "Drug hypersensitivity"@en .

<http://linked.opendata.cz/resource/ndfrt/disease/N0000001432> a ns1:DiseaseOrFinding ;
    ns1:description "Pathological conditions involving the HEART including its structural and functional abnormalities.     "@en ;
    ns1:title "Srdce - nemoci"@cs,
        "Heart diseases"@en .

<http://linked.opendata.cz/resource/ndfrt/disease/N0000001472> a ns1:DiseaseOrFinding ;
    ns1:description "A group of inherited disorders characterized by structural alterations within the hemoglobin molecule.     "@en ;
    ns1:title "Hemoglobinopatie"@cs,
        "Hemoglobinopathies"@en .

<http://linked.opendata.cz/resource/ndfrt/disease/N0000001509> a ns1:DiseaseOrFinding ;
    ns1:description "INFLAMMATION of the LIVER in humans caused by HEPATITIS C VIRUS, a single-stranded RNA virus. Its incubation period is 30-90 days. Hepatitis C is transmitted primarily by contaminated blood parenterally, and is often associated with transfusion and intravenous drug abuse. However, in a significant number of cases, the source of hepatitis C infection is unknown.     "@en ;
    ns1:title "Hepatitida c"@cs,
        "Hepatitis c"@en .

<http://linked.opendata.cz/resource/ndfrt/disease/N0000001681> a ns1:DiseaseOrFinding ;
    ns1:description "Invasion of the host organism by microorganisms that can cause pathological conditions or diseases.     "@en ;
    ns1:title "Infekce"@cs,
        "Infection"@en .

<http://linked.opendata.cz/resource/ndfrt/disease/N0000003161> a ns1:DiseaseOrFinding ;
    ns1:description "A mosquito-borne viral illness caused by the WEST NILE VIRUS, a FLAVIVIRUS and endemic to regions of Africa, Asia, and Europe. Common clinical features include HEADACHE; FEVER; maculopapular rash; gastrointestinal symptoms; and lymphadenopathy. MENINGITIS; ENCEPHALITIS; and MYELITIS may also occur. The disease may occasionally be fatal or leave survivors with residual neurologic deficits. (From Joynt, Clinical Neurology, 1996, Ch26, p13; Lancet 1998 Sep 5;352(9130):767-71)     "@en ;
    ns1:title "Západonilská horečka"@cs,
        "West nile fever"@en .

<http://linked.opendata.cz/resource/ndfrt/disease/N0000003529> a ns1:DiseaseOrFinding ;
    ns1:description "A severe irreversible decline in the ability of kidneys to remove wastes, concentrate URINE, and maintain ELECTROLYTE BALANCE; BLOOD PRESSURE; and CALCIUM metabolism.     "@en ;
    ns1:title "Selhání ledvin"@cs,
        "Kidney failure"@en .

<http://linked.opendata.cz/resource/ndfrt/disease/N0000003803> a ns1:DiseaseOrFinding ;
    ns1:description "Pneumovirus infections caused by the RESPIRATORY SYNCYTIAL VIRUSES. Humans and cattle are most affected but infections in goats and sheep have been reported.     "@en ;
    ns1:title "Viry respirační syncyciální - infekce"@cs,
        "Respiratory syncytial virus infections"@en .

<http://linked.opendata.cz/resource/ndfrt/disease/N0000003952> a ns1:DiseaseOrFinding ;
    ns1:description "A chronic self-perpetuating hepatocellular INFLAMMATION of unknown cause, usually with HYPERGAMMAGLOBULINEMIA and serum AUTOANTIBODIES.     "@en ;
    ns1:title "Autoimunitní hepatitida"@cs,
        "Hepatitis, autoimmune"@en .

<http://linked.opendata.cz/resource/ndfrt/disease/N0000003954> a ns1:DiseaseOrFinding ;
    ns1:description "INFLAMMATION of the LIVER in humans that is caused by HEPATITIS C VIRUS lasting six months or more. Chronic hepatitis C can lead to LIVER CIRRHOSIS.     "@en ;
    ns1:title "Chronická hepatitida c"@cs,
        "Hepatitis c, chronic"@en .

<http://linked.opendata.cz/resource/ndfrt/disease/N0000010195> a ns1:DiseaseOrFinding ;
    ns1:description "The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH.     "@en ;
    ns1:title "Těhotenství"@cs,
        "Pregnancy"@en .

<http://linked.opendata.cz/resource/ndfrt/mechanism-of-action/N0000000133> a ns1:MechanismOfAction ;
    ns1:title "Enzyme Inhibitors"@en .

<http://linked.opendata.cz/resource/ndfrt/physiologic-effect/N0000008577> a ns1:PhysiologicEffect ;
    ns1:title "Decreased DNA Replication"@en .

<http://linked.opendata.cz/resource/ndfrt/physiologic-effect/N0000008853> a ns1:PhysiologicEffect ;
    ns1:title "Decreased RNA Replication"@en .

<http://linked.opendata.cz/resource/sukl/medicinal-product/COPEGUS-200-MG> a ns1:MedicinalProduct ;
    ns1:hasATCConcept <http://linked.opendata.cz/resource/ATC/J05AB04> ;
    ns1:title "COPEGUS 200 MG"@cs .

<http://linked.opendata.cz/resource/sukl/medicinal-product/REBETOL-200-MG> a ns1:MedicinalProduct ;
    ns1:hasATCConcept <http://linked.opendata.cz/resource/ATC/J05AB04> ;
    ns1:title "REBETOL 200 MG"@cs .

<http://linked.opendata.cz/resource/sukl/medicinal-product/REBETOL-40-MG-ML> a ns1:MedicinalProduct ;
    ns1:hasATCConcept <http://linked.opendata.cz/resource/ATC/J05AB04> ;
    ns1:title "REBETOL 40 MG/ML"@cs .

<http://linked.opendata.cz/resource/sukl/medicinal-product/RIBAVIRIN-BIOPARTNERS-200-MG> a ns1:MedicinalProduct ;
    ns1:hasATCConcept <http://linked.opendata.cz/resource/ATC/J05AB04> ;
    ns1:title "RIBAVIRIN BIOPARTNERS 200 MG"@cs .

<http://linked.opendata.cz/resource/sukl/medicinal-product/RIBAVIRIN-MYLAN-200-MG> a ns1:MedicinalProduct ;
    ns1:hasATCConcept <http://linked.opendata.cz/resource/ATC/J05AB04> ;
    ns1:title "RIBAVIRIN MYLAN 200 MG"@cs .

<http://linked.opendata.cz/resource/sukl/medicinal-product/RIBAVIRIN-MYLAN-200-MG-POTAHOVANE-TABLETY> a ns1:MedicinalProduct ;
    ns1:hasATCConcept <http://linked.opendata.cz/resource/ATC/J05AB04> ;
    ns1:title "RIBAVIRIN MYLAN 200 MG POTAHOVANÉ TABLETY"@cs .

<http://linked.opendata.cz/resource/sukl/medicinal-product/RIBAVIRIN-TEVA-200-MG> a ns1:MedicinalProduct ;
    ns1:hasATCConcept <http://linked.opendata.cz/resource/ATC/J05AB04> ;
    ns1:title "RIBAVIRIN TEVA 200 MG"@cs .

<http://linked.opendata.cz/resource/sukl/medicinal-product/RIBAVIRIN-TEVA-PHARMA-BV-200-MG> a ns1:MedicinalProduct ;
    ns1:hasATCConcept <http://linked.opendata.cz/resource/ATC/J05AB04> ;
    ns1:title "RIBAVIRIN TEVA PHARMA BV 200 MG"@cs .

<http://linked.opendata.cz/resource/sukl/medicinal-product/RIBAVIRIN-TEVA-PHARMA-BV-400-MG> a ns1:MedicinalProduct ;
    ns1:hasATCConcept <http://linked.opendata.cz/resource/ATC/J05AB04> ;
    ns1:title "RIBAVIRIN TEVA PHARMA BV 400 MG"@cs .

<http://linked.opendata.cz/resource/sukl/medicinal-product/VILARIB-200-MG-POTAHOVANE-TABLETY> a ns1:MedicinalProduct ;
    ns1:hasATCConcept <http://linked.opendata.cz/resource/ATC/J05AB04> ;
    ns1:title "VILARIB 200 MG POTAHOVANÉ TABLETY"@cs .

<http://linked.opendata.cz/resource/sukl/medicinal-product/VILARIB-200-MG-TVRDE-TOBOLKY> a ns1:MedicinalProduct ;
    ns1:hasATCConcept <http://linked.opendata.cz/resource/ATC/J05AB04> ;
    ns1:title "VILARIB 200 MG TVRDÉ TOBOLKY"@cs .

<http://linked.opendata.cz/resource/sukl/medicinal-product/VILARIB-400-MG-POTAHOVANE-TABLETY> a ns1:MedicinalProduct ;
    ns1:hasATCConcept <http://linked.opendata.cz/resource/ATC/J05AB04> ;
    ns1:title "VILARIB 400 MG POTAHOVANÉ TABLETY"@cs .

<http://linked.opendata.cz/resource/sukl/medicinal-product/VILARIB-600-MG-POTAHOVANE-TABLETY> a ns1:MedicinalProduct ;
    ns1:hasATCConcept <http://linked.opendata.cz/resource/ATC/J05AB04> ;
    ns1:title "VILARIB 600 MG POTAHOVANÉ TABLETY"@cs .


